Replies to post #6456 on Avid Bioservices Inc (CDMO)

[microbe_man]

Todays action.

First, I think this news is remarkable. For a single dose study to show ANY efficacy in patients who failed other therapies is very exciting.

As an interesting thought, many Hep-C patients are also HIV infected. If any patients were infected by both, I wonder what happened to their HIV viral titers?? I doubt this was measured, but it sure would be interesting to know.

I doubt a put is on the way. The only thing that I agree on with that idiot PKelley is that this news was known well before the PR and actually we went from 1.49 to where we are on the news. I think this accounts for the drop in price, the early buyers are getting out at a nice profit.

I could care less about the drop, I am adding to my already ridiculous number of shares